Abstract

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes

Author(s): Allen Loyd V Jr

Issue: May/Jun 2022 - Volume 26, Number 3

Page(s): 214-217

Download in electronic PDF format for $75
  • Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 1
  • Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 2
  • Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 3
  • Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Page 4

Abstract

Enteral feeding has increased in recent years along with the various methods and equipment utilized. Oftentimes, it is necessary to administer medications via enteral tubes, and care must be observed to maintain the proper flow through the tubes. This is done by proper maintenance to prevent clogging and even removing clogs if they occur. Proper choice of a vehicle to administer a drug is critical for the patient to receive the benefit of drug therapy and to properly maintain the usefulness of the enteral feeding.

Related Keywords

  • enteral feeding tubes
  • drug administration
  • tube blockage
  • tube patency
  • tube flushing
  • nasogastric tube
  • NG tube
  • nasoduodenal tube
  • nasojejunal tube
  • percutaneous gastrostomy tube
  • percutaneous jejunostomy tube
  • percutaneous gastrojejunostomy tube
  • methylcellulose vehicle
  • formulation

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • NUTRITION AND NUTRICEUTICALS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2022
Pg. 214-217
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 250-256
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
Author(s): de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
Jul/Aug 2010
Pg. 276-282
Recommendations for Compounding Medications for Feeding Tube Administration
Author(s): Klang Mark
May/Jun 2003
Pg. 206-207
Technology Spotlight: Tube Sealers
Author(s): Jones Michael, Adams Susan
Jul/Aug 2000
Pg. 304
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 320
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 383
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493
Basics of Compounding: Clinical Pharmaceutics, Part 2
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 1997
Pg. 13
Omeprazole (Prilosec) in the Atypical Patient, Administration of
Author(s): Kane Dana Lynn
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 217-222
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Author(s): Akers Michael J
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
Nov/Dec 2023
Pg. 474-481
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 296-297
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Author(s): Brunner Scott
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R